CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
93 hedge funds and large institutions have $42.2M invested in Carisma Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
58% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $3.08M
Holders
93
Holding in Top 10
–
Calls
$1.28M
Puts
$3.08M
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.76M | |
| 3 | +$1.54M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$549K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$364K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.56M | |
| 3 | -$1.48M | |
| 4 |
Renaissance Technologies
New York
|
-$1.25M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$996K |